Latest 3 "buy" recommendations from top brokers

The S&P/ASX 200 Index (Index:^AXJO) is surging higher and the good times are likely continue. Here are 3 stocks brokers are urging you to buy.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (Index:^AXJO) is surging higher and the good times are likely to roll on. Markets are embracing a Joe Biden US presidency and prospects of greater central bank stimulus.

It's hard to see what could sink the ongoing rally – barring an unexpected black swan event. This should clear the way for a decent Santa Rally.

Here are the latest three ASX stocks that brokers are urging you to buy today.

ASX shares Hand writing Time to Buy concept clock with blue marker on transparent wipe board.

Image source: Getty Images

Buy Macquarie for rebound potential

The Macquarie Group Ltd (ASX: MQG) share price is one to watch following its first half profit results.

The bank's interim dividend of $1.35 was around 8% below consensus and the slightly better than expected profit result was driven by the "lumpy" divisions in the bank.

But Morgan Stanley isn't perturbed and it reiterated its "overweight" recommendation on the Macquarie share price.

"We think 1H21 was a low point for earnings," said the broker.

"The combination of a better outlook for gains on sale & performance fees, solid MIRA flows, and lower impairments should stabilise earnings in 2H21, with 30% recovery in FY22, in our view."

What's more, Morgan Stanley reckons impairment losses at the bank has peaked with better than expected outcomes for most divisions.

The broker's 12-month price target on the stock is $148 a share.

Well wrapped for Santa Rally

Meanwhile, the Amcor CDI (ASX: AMC) share price is another to put on your watchlist following its quarterly results.

The analysts at Macquarie repeated the "outperform" rating on the packaging group as they describe Amcor as an attractive, resilient and defensive business.

"The US has been a strong point for most companies in Q3, and AMC was no exception, with North America flexibles vols up mid-single digit (vs low single digit in 2H20)," said the broker.

"Rigids also saw improved momentum, with vols +4% vs +1% in 2H20, driven by improved sequential demand in the US convenience channel and likely pantry-filling (again) of Gatorade."

Despite these positives, the Amcor share price is trading at a discount to peers and its historical average.

Amcor is priced at a 20% discount to the ASX 100 when the 10-year average is a 7% premium. Macquarie's 12-month price target on Amcor is $17.85 a share.

The good oil to fire up the NUF share price

The embattled Nufarm Limited (ASX: NUF) share price could make a comeback with Citigroup reiterating its "buy" call on the stock.

There is a close to 50% total return upside to the NUF share price based on the broker's estimates. Earnings growth from the agri-business group's omega-3 oil enriched canola seeds is a key driver for this bullish call.

"While the initial earnings contribution should be small, we see omega-3 canola as a material long term earnings driver for Nufarm," said Citi.

"Based on our own bottom-up analysis of fish oil demand for the global aquaculture industry, we estimate a ~418kt pa demand deficit will emerge by 2028."

The new omega-3 products is estimated to be worth up to $1.57 a share for Nufarm and Citi's 12-month price target on the stock is $5.30 a share.

Motley Fool contributor Brendon Lau owns shares of Macquarie Group Limited and Nufarm Limited. The Motley Fool Australia owns shares of and has recommended Amcor Limited and Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cheap Shares

patient with doctor, medical company, medical insurance
Cheap Shares

CSL shares trade at just 12 times forecast earnings. Here's why they could be the buy of the decade

The ASX 200 healthcare giant is down more than 60% since August 2025.

Read more »

A white and black clock face is shown with Time to Buy written.
Cheap Shares

2 ASX shares tipped to grow 90% or more in the next 12 months

These businesses are expected to deliver significant returns.

Read more »

A man reacts with surprise when her see a bargain price on his phone.
Cheap Shares

This ASX 300 share is down 63% in 2026: Experts think it's a buy!

This business could be a great contrarian buy.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Cheap Shares

Down 40%+! 2 cheap ASX shares I'd buy before the recovery becomes obvious

The best recovery opportunities can appear before the good news is obvious. I think these two ASX shares are worth…

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Cheap Shares

3 cheap ASX 200 shares to buy with $5,000

Big returns could be on offer with these cheap shares according to analysts.

Read more »

Rising arrow on a piggy bank with a woman holding it and smiling.
Growth Shares

2 ASX growth shares to buy with big growth potential!

Analysts are excited about the prospects of these businesses…

Read more »

A male ASX investor on the street wearing a grey suit clenches his fist and yells yes after seeing on his ipad that the Paladin share price is going up again today
Cheap Shares

These 3 oversold ASX 200 shares look cheap right now

One of these ASX 200 shares is tipped to increase 100% in the next 12 months!

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Cheap Shares

2 ASX shares highly recommended to buy: Experts

These businesses could produce strong returns…

Read more »